Brown Brothers Harriman & Co’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.9K Sell
296
-107
-27% -$16.2K ﹤0.01% 954
2025
Q1
$60.7K Buy
403
+14
+4% +$2.11K ﹤0.01% 794
2024
Q4
$71.8K Buy
389
+255
+190% +$47.1K ﹤0.01% 802
2024
Q3
$26.4K Buy
134
+9
+7% +$1.77K ﹤0.01% 897
2024
Q2
$25.8K Sell
125
-95
-43% -$19.6K ﹤0.01% 857
2024
Q1
$59.6K Hold
220
﹤0.01% 736
2023
Q4
$52K Buy
220
+95
+76% +$22.5K ﹤0.01% 726
2023
Q3
$24.5K Sell
125
-419
-77% -$82.1K ﹤0.01% 805
2023
Q2
$114K Sell
544
-9,048
-94% -$1.9M ﹤0.01% 569
2023
Q1
$1.94M Buy
9,592
+4,611
+93% +$931K 0.02% 177
2022
Q4
$1.09M Buy
4,981
+1,008
+25% +$220K 0.01% 213
2022
Q3
$782K Buy
3,973
+576
+17% +$113K 0.01% 244
2022
Q2
$727K Buy
3,397
+293
+9% +$62.7K 0.01% 262
2022
Q1
$881K Buy
3,104
+460
+17% +$131K 0.01% 266
2021
Q4
$996 Buy
2,644
+67
+3% +$25 0.01% 242
2021
Q3
$1.06K Buy
2,577
+182
+8% +$75 0.01% 217
2021
Q2
$886 Buy
2,395
+2,304
+2,532% +$852 0.01% 246
2021
Q1
$26 Sell
91
-7
-7% -$2 ﹤0.01% 744
2020
Q4
$24K Sell
98
-50
-34% -$12.2K ﹤0.01% 764
2020
Q3
$34K Buy
148
+28
+23% +$6.43K ﹤0.01% 628
2020
Q2
$21K Hold
120
﹤0.01% 680
2020
Q1
$15K Buy
120
+12
+11% +$1.5K ﹤0.01% 664
2019
Q4
$16K Sell
108
-1,500
-93% -$222K ﹤0.01% 823
2019
Q3
$213K Hold
1,608
﹤0.01% 418
2019
Q2
$228K Hold
1,608
﹤0.01% 375
2019
Q1
$234K Buy
1,608
+85
+6% +$12.4K ﹤0.01% 360
2018
Q4
$172K Buy
1,523
+23
+2% +$2.6K ﹤0.01% 364
2018
Q3
$202K Buy
+1,500
New +$202K ﹤0.01% 362
2018
Q1
Sell
-105
Closed -$11K 872
2017
Q4
$11K Buy
105
+90
+600% +$9.43K ﹤0.01% 740
2017
Q3
$2K Hold
15
﹤0.01% 712
2017
Q2
$2K Hold
15
﹤0.01% 726
2017
Q1
$1K Buy
+15
New +$1K ﹤0.01% 773